Haematology Research Review, Issue 14

In this Issue:

Rapid rituximab clearance and haematological complications in CLL
Health-related QOL in imatinib-treated CML
Outcomes of critically ill patients with haematological malignancies
Obinutuzumab plus CHOP or FC in relapsed/refractory follicular lymphoma
Obinutuzumab in relapsed/refractory DLBCL or MCL
Surveillance PET–CT in DLBCL
Bortezomib-dexamethasone ±cyclophosphamide or lenalidomide in MM
Bortezomib, doxorubicin and dexamethasone
for relapsed/refractory MM
Treatment-related mortality in advanced-stage Hodgkin’s lymphoma
Outcomes of elderly patients with AML

Please login below to download this issue (PDF)